A1C Almanac

Main Page

The Bioactive Power of Matcha: Perspectives on Metabolic Regulation, Microbiome Modulation, and Longevity Pathways

Posted

by

dr Leonard Andreas Wiyadharma, BMedSci

Table of Contents
Category:

Introduction

The global burden of metabolic disorders, including type 2 diabetes mellitus, obesity, and cardiovascular disease, continues to escalate, necessitating innovative preventive and therapeutic approaches [1–3]. Traditional plant-based interventions have emerged as promising complementary strategies in metabolic health management [4], with green tea derivatives receiving particular scientific scrutiny. Among these, matcha green tea represents a unique form of Camellia sinensis consumption that delivers concentrated bioactive compounds through whole-leaf ingestion rather than water extraction alone.

Matcha’s distinct cultivation process, involving pre-harvest shading for 3-4 weeks, significantly enhances the concentration of catechins, particularly EGCG, amino acids such as L-theanine, and chlorophyll content compared to conventional green teas. This processing methodology results in a product with superior antioxidant capacity and potential therapeutic efficacy for metabolic disorders.

Recent advances in longevity research have identified key biological pathways associated with healthy aging, including mitochondrial function, cellular senescence, inflammatory regulation, and metabolic homeostasis [5–8]. The intersection of these pathways with matcha’s bioactive compounds presents compelling opportunities for evidence-based interventions in preventive medicine.

Chemical Composition and Antioxidant Properties

Bioactive Compound Profile

Matcha’s therapeutic potential stems from its unique phytochemical composition, characterized by exceptionally high concentrations of catechins, particularly EGCG, which comprises 50-80% of total catechins [9, 10]. Recent analytical studies demonstrate that high-grade matcha contains 137-141 mg of catechins per gram of powder, with EGCG concentrations reaching 61-76 mg/g, significantly exceeding those found in conventional green tea preparations [11, 12].

The amino acid profile of matcha is equally distinctive, with L-theanine concentrations ranging from 9.85-16.1 mg/g, contributing to its unique neurological effects and potential stress-modulating properties [13]. Additional bioactive compounds include caffeine (18.9-44.4 mg/g) [14], vitamin C [15], vitamin K [13], β-carotene, and various flavonoids including quercetin and rutin [16].

Antioxidant Capacity Assessment

Multiple studies have evaluated matcha’s antioxidant capacity using standardized assays including DPPH (2,2-diphenyl-1-picrylhydrazyl), ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)), and FRAP (ferric reducing antioxidant power) methods [17–19]. A comprehensive antioxidant performance index (APC) analysis revealed that certain matcha cultivars, particularly Longjing 43, demonstrate superior antioxidant capacity across multiple assessment parameters [20].

Research indicates that matcha’s water-soluble antioxidants exhibit significant free radical scavenging activity, while lipid-soluble compounds contribute substantially to overall antioxidant protection [13]. Notably, the bioavailability of matcha polyphenols appears enhanced during digestion compared to traditional green tea preparations, with in vitro digestion studies demonstrating superior antioxidant and antidiabetic activity retention [13, 21].

Metabolic Health Benefits

Glucose Homeostasis and Insulin Sensitivity

Mechanisms of Glycemic Control

Recent clinical and preclinical research has elucidated multiple mechanisms through which matcha influences glucose homeostasis. EGCG, the primary bioactive catechin, demonstrates potent α-glucosidase inhibitory activity, effectively reducing postprandial glucose elevations by inhibiting carbohydrate digestion and absorption [22, 23]. This mechanism is particularly relevant for diabetes management, as α-glucosidase inhibitors represent a standard therapeutic approach for postprandial glucose control [22].

Furthermore, EGCG enhances glucose uptake in skeletal muscle through improved GLUT4 (glucose transporter 4) translocation, a mechanism fundamental to insulin-independent glucose utilization [24]. Studies in diabetic rodent models demonstrate that green tea consumption significantly ameliorates glucose intolerance through enhanced skeletal muscle glucose uptake and improved insulin signaling pathways [24, 25].

Clinical Evidence for Diabetes Management

Human clinical trials investigating matcha’s effects on glycemic control have yielded mixed but promising results. A randomized controlled trial examining green tea extract (500 mg three times daily for 16 weeks) in patients with type 2 diabetes demonstrated significant improvements in HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)[26].

However, systematic reviews and meta-analyses present more cautious interpretations. A comprehensive meta-analysis found no significant differences between green tea extract and placebo for glycosylated hemoglobin (HbA1c), HOMA-IR, fasting insulin, or fasting glucose when analyzed across heterogeneous populations [27]. A separate meta-analysis found that green tea significantly lowered fasting blood glucose by 1.44 mg/dL but had no significant effect on fasting insulin or HbA1c [28]. These findings suggest that individual responses to matcha may be influenced by baseline metabolic status, genetic factors, and concurrent lifestyle interventions.

Lipid Profile and Cardiovascular Health

Lipid Metabolism Modulation

Matcha consumption demonstrates significant effects on lipid metabolism through multiple molecular pathways. EGCG inhibits the expression of lipogenic genes including fatty acid synthase (FAS), stearoyl-CoA desaturase-1 (SCD1), and sterol regulatory element-binding protein-1 (SREBP1), resulting in reduced hepatic lipogenesis and enhanced free fatty acid excretion [29, 30].

Animal studies consistently demonstrate that matcha supplementation prevents high-fat diet-induced obesity, reduces visceral adipose tissue accumulation, and improves hepatic steatosis [20, 31, 32]. These effects are accompanied by favorable changes in serum lipid profiles, including reduced total cholesterol, triglycerides, and LDL cholesterol, with concurrent increases in HDL cholesterol concentrations [32, 33].

Cardiovascular Disease Prevention

Large-scale meta-analyses examining tea consumption and cardiovascular outcomes present nuanced findings. While observational studies suggest protective associations, a recent Mendelian randomization study indicate no causal relationship between tea consumption and cardiovascular disease incidence, including coronary artery disease, myocardial infarction, heart failure, and ischemic stroke [34].

However, mechanistic studies demonstrate that catechins effectively lower blood pressure and improve endothelial function through enhanced nitric oxide bioavailability and reduced oxidative stress [35]. A systematic review and meta-analysis revealed that green tea extract supplementation significantly reduced diastolic blood pressure [36, 37].

Weight Management and Body Composition

Clinical evidence supports matcha’s role in weight management and body composition improvement. A randomized controlled study demonstrated that matcha consumption enhances exercise-induced fat oxidation in females during moderate-intensity physical activity. Participants consuming matcha experienced significantly lower respiratory exchange ratios and enhanced fat oxidation rates compared to controls [38].

The weight management effects of matcha appear mediated through multiple mechanisms including enhanced thermogenesis, improved fat oxidation, and modulation of appetite-regulating hormones [39]. EGCG influences hypothalamic microglial activity, reducing neuroinflammation and preserving energy homeostatic function, ultimately contributing to appetite regulation and body weight control [39].

Anti-Aging and Longevity Mechanisms

Cellular Senescence and Aging Biomarkers

Recent research has identified compelling mechanisms through which matcha consumption may influence aging processes and longevity. A landmark study demonstrated that long term EGCG supplementation in mice resulted in a ~47% reduction in average mortality risk [40]. This longevity benefit was associated with significant reductions in senescence-associated protein p21 levels in adipose tissue and enhanced autophagy markers (LC3-II) in both adipose and intestinal tissues [40].

The anti-aging effects of EGCG appear mediated through activation of key longevity pathways including AMPK (AMP-activated protein kinase) and SIRT1 (sirtuin 1). These pathways are fundamental to cellular energy homeostasis and stress response, with their activation promoting cellular survival, metabolic efficiency, and resistance to age-related dysfunction [40, 41].

Mitochondrial Function and Bioenergetics

Matcha catechins exert complex effects on mitochondrial function that contribute to longevity benefits. While acute EGCG exposure initially inhibits mitochondrial complex I activity, resulting in transient ATP depletion and ROS elevation, these effects trigger adaptive responses that ultimately enhance cellular resilience and longevity [42].

Long-term catechin exposure promotes mitochondrial biogenesis [41], enhances antioxidant enzyme activities (superoxide dismutase and catalase) [42, 43], and improves cellular energy efficiency [44, 45]. These adaptations represent a form of hormetic response, wherein mild metabolic stress enhances cellular stress resistance and promotes healthy aging.

Telomere Maintenance and Epigenetic Regulation

Emerging evidence suggests that green tea polyphenols influence telomere biology and epigenetic aging markers [46, 47]. Longitudinal studies demonstrate associations between regular tea consumption and attenuated biological aging as measured by composite biomarker panels and telomere length preservation [48, 49].

EGCG demonstrates differential effects on telomeric regulation between normal and malignant cells, promoting telomere stability in healthy fibroblasts while inducing telomere dysfunction in cancer cells [50, 51]. This selective activity suggests potential applications in both healthy aging promotion and cancer prevention.

Gut Microbiome and Metabolic Health

Microbiome Modulation

Recent research has identified the gut-liver axis as a critical target for matcha’s metabolic health benefits. High-fat diet studies demonstrate that matcha supplementation significantly modulates gut microbial composition, enhancing beneficial bacterial populations including Alloprevotella, Ileibacterium, and Rikenella while reducing obesity-promoting species such as Romboutsia [20, 52].

These microbiome changes correlate with improved metabolic outcomes including reduced adipose tissue accumulation, enhanced glucose tolerance, and improved hepatic function. The mechanisms appear to involve modulation of short-chain fatty acid production, bile acid metabolism, and inflammatory mediator regulation [20, 52, 53].

Metabolomic Effects

Untargeted metabolomics analyses reveal that matcha consumption significantly influences gut metabolite profiles. Key metabolic changes include alterations in formononetin, glutamic acid, pyroglutamic acid, and bile acid conjugates [52]. These metabolites demonstrate significant correlations with obesity-related phenotypes and may represent biomarkers for metabolic health status.

Pathway analysis indicates that matcha enhances caffeine metabolism and activates HIF-1 (hypoxia-inducible factor-1) signaling pathways, potentially contributing to improved cellular oxygen utilization and metabolic efficiency [52, 54].

Clinical Applications and Therapeutic Considerations

Dosage and Administration Protocols

Clinical studies investigating matcha’s therapeutic effects have employed varying dosage protocols, typically ranging from 500-2000 mg daily of standardized extract or 2-6 grams of matcha powder [26, 55, 56]. The optimal dosing strategy appears to depend on specific therapeutic goals, with metabolic health benefits observed at moderate doses (1-2 g daily) [57, 58] and cognitive effects demonstrated at higher concentrations [59].

Timing of administration may influence the metabolic efficacy of matcha, with evening consumption showing greater improvements in postprandial glucose control compared to morning intake. A study in 2019 demonstrated that evening ingestion of catechin-rich green tea significantly reduced postprandial glucose [60], while a 2025 follow-up study found that green tea (poly)phenols delay postprandial insulin primarily in the morning but not in the evening [61]. These findings underscore the importance of chronotherapy in optimizing matcha’s metabolic benefits.

Safety Profile and Contraindications

Matcha demonstrates an excellent safety profile in clinical studies, with adverse effects primarily limited to mild gastrointestinal symptoms at high doses [55, 62, 63]. However, practitioners should consider potential interactions with anticoagulant medications due to matcha’s vitamin K content and possible additive effects with other caffeinated substances.

Hepatotoxicity concerns associated with green tea extract supplements appear primarily related to concentrated extracts consumed on empty stomach, with whole matcha powder demonstrating superior tolerability profiles [55, 63, 64].

Conclusions

Current evidence supports matcha’s role as a valuable adjunctive intervention in metabolic health management and healthy aging promotion. The unique bioactive compound profile of matcha, particularly its high EGCG content, contributes to beneficial effects on glucose homeostasis, lipid metabolism, inflammatory regulation, and cellular aging processes.

While individual clinical trial results show promise, the heterogeneity of study populations, dosing protocols, and outcome measures limits definitive therapeutic recommendations. The most robust evidence supports matcha’s role in postprandial glucose control, lipid profile improvement, and exercise-induced fat oxidation enhancement.

The longevity research presents particularly compelling mechanistic insights, with EGCG demonstrating significant lifespan extension in animal models through senescence reduction and autophagy enhancement. However, translation to human applications requires additional long-term clinical trials with standardized protocols and validated aging biomarkers.

For clinical practitioners in preventive medicine, matcha represents a evidence-based, low-risk intervention that may complement conventional metabolic health management strategies. Optimal therapeutic protocols likely involve moderate daily doses (1-2 grams) combined with lifestyle modifications including regular physical activity and structured dietary interventions.

Future research priorities should focus on standardized clinical protocols, personalized medicine applications, and long-term safety and efficacy studies in diverse populations. The integration of metabolomics, microbiome analysis, and aging biomarkers will enhance our understanding of matcha’s therapeutic mechanisms and optimize clinical applications.

References

  1. Chen J, Fu D, Ma T, et al. Global burden of metabolic disorders among women of child-bearing age, 1990–2021: a population-based study. BMC Womens Health 2025; 25: 207.
  2. Martin SS, Aday AW, Almarzooq ZI, et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation; 149. Epub ahead of print 20 February 2024. DOI: 10.1161/CIR.0000000000001209.
  3. Zhang H, Zhou X-D, Shapiro MD, et al. Global burden of metabolic diseases, 1990–2021. Metabolism 2024; 160: 155999.
  4. Song L, Zhang S. Anti-Aging Activity and Modes of Action of Compounds from Natural Food Sources. Biomolecules; 13. Epub ahead of print 31 October 2023. DOI: 10.3390/biom13111600.
  5. López-Otín C, Blasco MA, Partridge L, et al. The Hallmarks of Aging. Cell 2013; 153: 1194–1217.
  6. López-Otín C, Blasco MA, Partridge L, et al. Hallmarks of aging: An expanding universe. Cell 2023; 186: 243–278.
  7. Rodea S, Solórzano E. Cellular senescence as a quality parameter in chronological aging. Acta Bioclínica 2023; 13: 258–280.
  8. Rea IM, Gibson DS, McGilligan V, et al. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Front Immunol; 9. Epub ahead of print 9 April 2018. DOI: 10.3389/fimmu.2018.00586.
  9. Rawangkan A, Kengkla K, Kanchanasurakit S, et al. Anti-Influenza with Green Tea Catechins: A Systematic Review and Meta-Analysis. Molecules; 26. Epub ahead of print 30 June 2021. DOI: 10.3390/molecules26134014.
  10. Olson KR, Briggs A, Devireddy M, et al. Green tea polyphenolic antioxidants oxidize hydrogen sulfide to thiosulfate and polysulfides: A possible new mechanism underpinning their biological action. Redox Biol 2020; 37: 101731.
  11. Landau R, Sittiprapaporn P. The Comparison of Epigallocatechin Gallate Levels in Matcha Powders in Ceremonial, Premium and Culinary Grade by HPLC Method. Chiang Rai, 9 July 2025.
  12. Sokary S, Al-Asmakh M, Zakaria Z, et al. The therapeutic potential of matcha tea: A critical review on human and animal studies. Curr Res Food Sci 2023; 6: 100396.
  13. Koláčková T, Sumczynski D, Minařík A, et al. The Effect of In Vitro Digestion on Matcha Tea (Camellia sinensis) Active Components and Antioxidant Activity. Antioxidants (Basel); 11. Epub ahead of print 30 April 2022. DOI: 10.3390/antiox11050889.
  14. Alsenani F, Alotaiq N, Dermawan D, et al. Understanding the role of green tea and matcha consumption in cardiovascular health, obesity, and diabetes: Insights from a Saudi Arabian population. Human Nutrition & Metabolism 2025; 40: 200302.
  15. Jakubczyk K, Szymczykowska K, Kika J, et al. Exploring the Influence of Origin, Harvest Time, and Cultivation Method on Antioxidant Capacity and Bioactive Compounds of Matcha Teas. Foods; 13. Epub ahead of print 21 April 2024. DOI: 10.3390/foods13081270.
  16. Liu Y, Wu D, Tang P, et al. A HPLC Method for Detection of 17 Characteristic Components in Tea Extract. Am J Biochem Biotechnol 2022; 18: 41–48.
  17. Rumpf J, Burger R, Schulze M. Statistical evaluation of DPPH, ABTS, FRAP, and Folin-Ciocalteu assays to assess the antioxidant capacity of lignins. Int J Biol Macromol 2023; 233: 123470.
  18. Lee L-S, Kim S-H, Kim Y-B, et al. Quantitative analysis of major constituents in green tea with different plucking periods and their antioxidant activity. Molecules 2014; 19: 9173–86.
  19. Jakubczyk K, Kochman J, Kwiatkowska A, et al. Antioxidant Properties and Nutritional Composition of Matcha Green Tea. Foods; 9. Epub ahead of print 12 April 2020. DOI: 10.3390/foods9040483.
  20. Wang Y, Yu Y, Ding L, et al. Matcha green tea targets the gut-liver axis to alleviate obesity and metabolic disorders induced by a high-fat diet. Front Nutr 2022; 9: 931060.
  21. Rusak G, Šola I, Vujčić Bok V. Matcha and Sencha green tea extracts with regard to their phenolics pattern and antioxidant and antidiabetic activity during in vitro digestion. J Food Sci Technol 2021; 58: 3568–3578.
  22. Orita T, Chogahara S, Okuda M, et al. Extraction Efficiency and Alpha-Glucosidase Inhibitory Activities of Green Tea Catechins by Different Infusion Methods. Foods; 12. Epub ahead of print 6 July 2023. DOI: 10.3390/foods12132611.
  23. Li T, Liu J, Zhang X, et al. Antidiabetic activity of lipophilic (−)-epigallocatechin-3-gallate derivative under its role of α-glucosidase inhibition. Biomedicine & Pharmacotherapy 2007; 61: 91–96.
  24. Ueda-Wakagi M, Hayashibara K, Nagano T, et al. Epigallocatechin gallate induces GLUT4 translocation in skeletal muscle through both PI3K- and AMPK-dependent pathways. Food Funct 2018; 9: 4223–4233.
  25. Ueda-Wakagi M, Nagayasu H, Yamashita Y, et al. Green tea ameliorates hyperglycemia by promoting the translocation of glucose transporter 4 in the skeletal muscle of diabetic rodents. Int J Mol Sci; 20. Epub ahead of print 2 May 2019. DOI: 10.3390/ijms20102436.
  26. Liu C-Y, Huang C-J, Huang L-H, et al. Effects of Green Tea Extract on Insulin Resistance and Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes and Lipid Abnormalities: A Randomized, Double-Blinded, and Placebo-Controlled Trial. PLoS One 2014; 9: e91163.
  27. Yu J, Song P, Perry R, et al. The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis. Diabetes Metab J 2017; 41: 251–262.
  28. Xu R, Bai Y, Yang K, et al. Effects of green tea consumption on glycemic control: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab (Lond) 2020; 17: 56.
  29. Suzuki T, Kumazoe M, Kim Y, et al. Green Tea Extract Containing a Highly Absorbent Catechin Prevents Diet-Induced Lipid Metabolism Disorder. Sci Rep 2013; 3: 2749.
  30. Zhang Y, Yin R, Lang J, et al. Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet. Diabetol Metab Syndr 2022; 14: 53.
  31. Zhou D-D, Mao Q-Q, Li B-Y, et al. Effects of Different Green Teas on Obesity and Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Front Nutr; 9. Epub ahead of print 24 June 2022. DOI: 10.3389/fnut.2022.929210.
  32. Xu P, Ying L, Hong G, et al. The effects of the aqueous extract and residue of Matcha on the antioxidant status and lipid and glucose levels in mice fed a high-fat diet. Food Funct 2016; 7: 294–300.
  33. Xu R, Yang K, Li S, et al. Effect of green tea consumption on blood lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr J 2020; 19: 48.
  34. Chen L, Sun X, Zheng L. No causal effect of tea consumption on cardiovascular diseases: A two-sample Mendelian randomization study. Front Cardiovasc Med; 9. Epub ahead of print 7 September 2022. DOI: 10.3389/fcvm.2022.870972.
  35. Bottino DA, Nogueira DCG, Bouskela E. Low dose of green tea catechins improves endothelial function and vascular smooth muscle cell reactivity in obese women. Medical Express; 1. Epub ahead of print 2014. DOI: 10.5935/MedicalExpress.2014.05.09.
  36. Peng X, Zhou R, Wang B, et al. Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep 2014; 4: 6251.
  37. Liu G, Mi X-N, Zheng X-X, et al. Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. British Journal of Nutrition 2014; 112: 1043–1054.
  38. Willems MET, Şahin MA, Cook MD. Matcha Green Tea Drinks Enhance Fat Oxidation During Brisk Walking in Females. Int J Sport Nutr Exerc Metab 2018; 28: 536–541.
  39. Zhou J, Mao L, Xu P, et al. Effects of (−)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet. Nutrients 2018; 10: 1681.
  40. Sharma R, Kumar R, Sharma A, et al. Long term consumption of green tea EGCG enhances healthspan and lifespan in mice by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis and immunosenescence. Epub ahead of print 4 January 2021. DOI: 10.1101/2021.01.01.425058.
  41. Xiong L-G, Chen Y-J, Tong J-W, et al. Epigallocatechin-3-gallate promotes healthy lifespan through mitohormesis during early-to-mid adulthood in Caenorhabditis elegans. Redox Biol 2018; 14: 305–315.
  42. Tian J, Geiss C, Zarse K, et al. Green tea catechins EGCG and ECG enhance the fitness and lifespan of Caenorhabditis elegans by complex I inhibition. Aging 2021; 13: 22629–22648.
  43. Simos Y V, Verginadis II, Toliopoulos IK, et al. Effects of catechin and epicatechin on superoxide dismutase and glutathione peroxidase activity, in vivo. Redox Rep 2012; 17: 181–6.
  44. Chen B, Zhang W, Lin C, et al. A Comprehensive Review on Beneficial Effects of Catechins on Secondary Mitochondrial Diseases. Int J Mol Sci 2022; 23: 11569.
  45. Castellano-González G, Pichaud N, Ballard JWO, et al. Epigallocatechin-3-gallate induces oxidative phosphorylation by activating cytochrome c oxidase in human cultured neurons and astrocytes. Oncotarget 2016; 7: 7426–40.
  46. Villanueva JL, Vita AA, Zwickey H, et al. Dietary associations with reduced epigenetic age: a secondary data analysis of the methylation diet and lifestyle study. Aging. Epub ahead of print 17 April 2025. DOI: 10.18632/aging.206240.
  47. Yilmaz Y. Green Tea Mitigates the Hallmarks of Aging and Age-Related Multisystem Deterioration. Aging Dis 2013; 0.
  48. Sohn I, Shin C, Baik I. Associations of green tea, coffee, and soft drink consumption with longitudinal changes in leukocyte telomere length. Sci Rep 2023; 13: 492.
  49. Xiang Y, Xu H, Chen H, et al. Tea consumption and attenuation of biological aging: a longitudinal analysis from two cohort studies. Lancet Reg Health West Pac 2024; 42: 100955.
  50. Pointner A, Mölzer C, Magnet U, et al. The green tea polyphenol EGCG is differentially associated with telomeric regulation in normal human fibroblasts versus cancer cells. Functional Foods in Health and Disease 2021; 11: 73.
  51. Talib WH, Awajan D, Alqudah A, et al. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. Molecules 2024; 29: 1373.
  52. Luo Y, Wen Y, Huang J, et al. Matcha alleviates obesity by modulating gut microbiota and its metabolites. Curr Res Food Sci 2024; 9: 100823.
  53. Münte E, Hartmann P. The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases. Biomolecules 2025; 15: 469.
  54. Tang Q, Liu K, Yue C, et al. CsXDH1 gene promotes caffeine catabolism induced by continuous strong light in tea plant. Hortic Res 2023; 10: uhad090.
  55. Mead MN. Temperance in green tea. Environ Health Perspect 2007; 115: A445.
  56. Sasagawa K, Domon H, Sakagami R, et al. Matcha Green Tea Exhibits Bactericidal Activity against Streptococcus pneumoniae and Inhibits Functional Pneumolysin. Antibiotics 2021; 10: 1550.
  57. Sokary S, Al-Asmakh M, Zakaria Z, et al. The therapeutic potential of matcha tea: A critical review on human and animal studies. Curr Res Food Sci 2023; 6: 100396.
  58. Willems MET, Fry HL, Belding MA, et al. Three Weeks Daily Intake of Matcha Green Tea Powder Affects Substrate Oxidation during Moderate-Intensity Exercise in Females. J Diet Suppl 2021; 18: 566–576.
  59. Baba Y, Inagaki S, Nakagawa S, et al. Effects of Daily Matcha and Caffeine Intake on Mild Acute Psychological Stress-Related Cognitive Function in Middle-Aged and Older Adults: A Randomized Placebo-Controlled Study. Nutrients; 13. Epub ahead of print 17 May 2021. DOI: 10.3390/nu13051700.
  60. Takahashi M, Ozaki M, Miyashita M, et al. Effects of timing of acute catechin-rich green tea ingestion on postprandial glucose metabolism in healthy men. J Nutr Biochem 2019; 73: 108221.
  61. Sulaimani N, Rosbotham EJ, Warnock R, et al. Time-of-day-dependent effects of a green tea extract on postprandial glycemia and insulinemia in healthy adults: a randomized, controlled, double-blind, cross-over intervention. Food Funct 2025; 16: 4122–4133.
  62. Isomura T, Suzuki S, Origasa H, et al. Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials. Eur J Clin Nutr 2016; 70: 1340.
  63. Hu J, Webster D, Cao J, et al. The safety of green tea and green tea extract consumption in adults – Results of a systematic review. Regulatory Toxicology and Pharmacology 2018; 95: 412–433.
  64. Oketch-Rabah HA, Roe AL, Rider C V., et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep 2020; 7: 386–402.

Discover more from A1C Almanac

Subscribe now to keep reading and get access to the full archive.

Continue reading